All Type of News
GSK Korea's Establishment of Vaccine Production Facility Still Under Discussion
In reaction to a number of reports recently made by the domestic daily newspapers that GlaxoSmithKline (GSK) Korea would establish a large-scale vaccine production facility in the Gyeonggi province, the company stated...
Retention of Experienced Personnel as Key Concern for Domestic Wholesalers
The domestic pharmaceutical wholesale community is expressing concerns over a recent trend where the manufacturing firms are recruiting a number of experienced people who previously worked at the wholesale companies.
...
Existing OTC Products with Renewed Versions to Attract More Demands
The domestic pharmaceutical firms are attempting to increase their over-the-counter (OTC) product sales by renewing the existing products with added ingredients and different packaging formats.
Given that the sales...
Kolmar Korea Ventures Into Oriental Medicine and Natural Remedies
Under a strategic objective to develop novel pharmaceutical and cosmetic products by utilizing natural ingredients and their efficacies derived from Chinese traditional medicines, Kolmar Korea has recently added two p...
Removal of Novarsc by Domestic Hospital
An industry source reported last week that the Severance Hospital Group has removed Pfizer Korea's Novarsc, an anti-hypertension drug, from its available group of prescription-based treatments.
According to the sou...
AstraZeneca Korea Completes Reorganization of Business Units
With the total revenue surpassing over 100 billion won from last year, AstraZeneca Korea recently completed a reorganization of company functions under its plan to drive growth on a long-term basis.
According to th...
Revised Government Standards Now Allow Public Advertising of OTC Products
The Korea Food and Drug Administration (KFDA) recently announced an official enforcement of its revised regulatory provision governing the public advertising standards for pharmaceutical products, which was proposed l...
Cialis Approved for 36-Hour Effectiveness Duration by KFDA
Lilly Korea recently announced that its male erectile dysfunction treatment, Cialis, has been approved by the Korea Food and Drug Administration (KFDA) for an extended duration of effectiveness lasting up to 36 hours....
Domestic Phase 3 Clinical Trials Total at 122 Items
The Korea Food and Drug Administration (KFDA) recently released the comprehensive list of pharmaceutical products that are currently undergoing the domestic phase 3 clinical trials.
Including new treatment candidat...
DMF Requirements Clarified by KFDA
The Korea Food and Drug Administration (KFDA) recently provided a set of specific details surrounding the Drug Master File (DMF) requirements, under its effort to implement the Pharmaceutical Bulk Report System schedu...
